UPLI is a biotech company building a therapeutic ingredient layer for food.

Our vision is simple: move food from cheap calories to ingredients that actively support our biology.

We're starting with unlocking the biological intelligence evolved in human milk proteins, building a pipeline of human milk proteins with proven roles in immunity, gut health, metabolism, and brain health. These ingredients are designed to shape healthspan from early life through adulthood.

Our first protein, human α-lactalbumin, is in development. It has the potential to bring infant formula much closer to breast-milk outcomes, improve tolerance and recovery in medical nutrition, and serve as a high-quality, tryptophan-rich protein for functional nutrition.

We’re looking to connect with early-stage investors who share our vision to rebuild the food system with biologically aligned, therapeutic ingredients.